NeuroMetrix’s Quell pain management wearable device is now available in approximately 1,000 chain drug stores as part of a test with two U.S. drug retailers, according to the company.
“Consumers have told us that they expect to see and purchase Quell at leading chain drug stores,” said Shai Gozani, president and CEO of NeuroMetrix. “We are therefore delighted to broaden the availability of Quell for the relief of widespread chronic pain. As Quell represents a new level of technology at premium pricing we will use learning from this test to optimize our full retail expansion.”
The Quell device is FDA cleared and designed for consumers suffering from chronic pain, according to the company. Quell gives users the option to start, stop and adjust therapy discreetly via their smartphone. It also enables sleep tracking that provides feedback on eight dimensions of sleep including sleep duration, quality, body position, time out of bed and repetitive leg movements throughout the night.